NORCO Drug Patent Profile
When do Norco patents expire, and what generic alternatives are available?
Norco is a drug marketed by Apil and is included in two NDAs.
The generic ingredient in NORCO is acetaminophen; hydrocodone bitartrate. There is one drug master file entry for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NORCO?
- What are the global sales for NORCO?
- What is Average Wholesale Price for NORCO?
Summary for NORCO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 661 |
| Drug Prices: | Drug price information for NORCO |
| Drug Sales Revenues: | Drug sales revenues for NORCO |
| DailyMed Link: | NORCO at DailyMed |
US Patents and Regulatory Information for NORCO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apil | NORCO | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 040148-004 | Jul 7, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apil | NORCO | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 040148-003 | Sep 12, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apil | NORCO | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 040099-001 | Jun 25, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apil | NORCO | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 040148-005 | Jul 7, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apil | NORCO | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 040148-001 | Feb 14, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
